Sales decline 8.51% to Rs 33.45 crore
Net profit of Kilitch Drugs (India) declined 60.12% to Rs 1.34 crore in the quarter ended June 2024 as against Rs 3.36 crore during the previous quarter ended June 2023. Sales declined 8.51% to Rs 33.45 crore in the quarter ended June 2024 as against Rs 36.56 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales33.4536.56 -9 OPM %4.9616.90 -PBDT2.505.24 -52 PBT1.654.53 -64 NP1.343.36 -60Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
